GeNO, LLC - Product Pipeline Analysis

1
GeNO, LLC - Product Pipeline AnalysisMarket
Research Reports Distributor - Aarkstore.com have
vast database on market research reports, company
financials, company profiles, SWOT analysis,
company report, company statistics, strategy
review, industry report, industry research to
provide excellent and innovative service to our
report buyers.Aarkstore.com have very
interactive search feature to browse across more
than 2,50,000 business industry reports. We are
built on the premise that reading is valuable,
capable of stirring emotions and firing the
imagination. Whether you're looking for new
market research report product trends or
competitive industry analysis of a new or
existing market, Aarkstore.com has the best
resource offerings and the expertise to make sure
you get the right product every time.
2
GeNO, LLC - Product Pipeline Analysis

• SummaryGeNO, LLC (GeNO) is a pharmaceutical
  company. It focuses on the development of inhaled
  nitric oxide drug products for the treatment of a
  multitude of human diseases. The companys product
  pipeline consists of three nitric oxide delivery
  platforms, namely, a stand-alone gas cylinder
  system for hospital and outpatient use, a
  ventilator-based platform for intensive care unit
  use, and a pocket-sized ambulatory system for
  chronic outpatient use. It uses the GeNO nitric
  oxide delivery technology for the development of
  its products. The company has offices in
  Massachusetts and Florida. GeNO is headquartered
  in Waltham, Massachusetts, the US.The company
  plans to advance its product pipeline. This
  intend is visible as recently GeNOs received a
  510(k) clearance for its GeNOs MV-1000 inhaled
  nitric oxide delivery system.This report is a
  source for data, analysis and actionable
  intelligence on the GeNO, LLC portfolio of
  pipeline products. The report provides detailed
  analysis on each pipeline product with
  information on the indication, the development
  stage, trial phase, product milestones, pipeline
  territory, estimated approval date, and estimated
  launch dateEach pipeline product is profiled to
  cover information on product description,
  function, technology, indication, and
  application. The report is also supplemented with
  a detailed company profile and information on
  clinical trials, wherever applicable.This
  report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  GlobalDatas team of industry experts.
• Scope- Detailed company profile with
  information on business description, key company
  facts, major products and services, key
  competitors, key employees, locations and
  subsidiaries and recent developments.- Detailed
  coverage on all the pipeline products, by
  equipment type, by therapy area, by development
  stage, and by trial phase.- Information on
  product milestones and pipeline territory for
  each product, the estimated approval date, and
  estimated launch date.

3

• - Profile of each pipeline product with
  additional information on product description,
  function, technology, indication(s), and
  application.- Data on relevant clinical trials
  and product patent details, wherever
  applicable.- Information on clinical trial,
  wherever applicable, is supplemented with
  information on trial phase, trial status, trial
  objective, trial design, target patients, unique
  physician identifier, primary point, secondary
  point, acronym, participants inclusion,
  participants exclusion, interventions, trial
  results, trial start date, trial end date, study
  type, trial site, trial funding, age eligibility,
  and gender eligibility.
• Reasons to Buy- Develop business strategies by
  understanding the trends and developments driving
  the medical devices pipeline and technology
  landscape globally.- Design and develop your
  product development, marketing and sales
  strategies.- Exploit MA opportunities by
  identifying market players with the most
  innovative pipeline.- Develop market-entry and
  market expansion strategies.- Exploit
  in-licensing and out-licensing opportunities by
  identifying products, most likely to ensure a
  robust return.- Identify emerging players with
  potentially strong product portfolio and create
  effective counter-strategies to gain competitive
  advantage.- Develop competition strategies by
  identifying the status and likely launch of your
  competitors pipeline products through review of
  the clinical trials, stage and phase of
  development, etc.- Which are the next high-value
  products that your competitor would add in its
  portfolio? identify, understand and capitalize.

4

• List of Tables 3List of Figures 3Key Facts
  4GeNO, LLC - Major Products and Services 5GeNO,
  LLC Pipeline Products by Equipment Type 6GeNO,
  LLC Pipeline Products by Development Stage
  8GeNO, LLC Pipeline Products by Therapy Area
  10GeNO, LLC Pipeline Products by Trial Phase
  12GeNO, LLC Pipeline Products by Milestone
  Summary 13GeNOSYL Nitrosyl Delivery Platform -
  Ambulatory System 15GeNOSYL Nitrosyl Delivery
  Platform - Ambulatory System Product Status
  15GeNOSYL Nitrosyl Delivery Platform -
  Ambulatory System Product Description 15NITROSYL
  System 16NITROSYL System Product Status
  16NITROSYL System Product Description
  16NITROSYL System Product Milestone 16NITROSYL
  System Clinical Trial 17NITROSYL System Product
  Patent Details 19Ventilator-Based Platform -
  Intensive Care Unit Use 24Ventilator-Based
  Platform - Intensive Care Unit Use Product Status
  24Ventilator-Based Platform - Intensive Care
  Unit Use Product Description 24GeNO, LLC - Key
  Competitors 25GeNO, LLC - Key Employees 26GeNO,
  LLC - Locations And Subsidiaries 27Head Office
  27Other Locations Subsidiaries 27Recent
  Developments 28GeNO, LLC, Recent Developments
  28Aug 21, 2012 GeNO Receives Four Additional
  Patents For Inhaled Nitric Oxide Delivery 28Aug
  21, 2012 GeNO Receives Four Additional Patents
  For Inhaled Nitric Oxide Delivery 28Jan 19,
  2012 GeNO Announces Management Changes 29Dec
  15, 2011 GeNO Receives Two New Patents For
  Nitric Oxide Delivery Technology 29Appendix
  31Methodology 31About GlobalData 31Contact Us
  31Disclaimer 31

5

• List of Tables GeNO, LLC, Key Facts 1GeNO, LLC
  Key Pipeline Products by Equipment Type 1GeNO,
  LLC Key Pipeline Products by Therapy Area 1GeNO,
  LLC Key Pipeline Products by Development Stage
  1GeNO, LLC Key Pipeline Products by Trial Phase
  1GeNO, LLC, Key Facts 4GeNO, LLC, Major
  Products and Services 5GeNO, LLC Number of
  Pipeline Products by Equipment Type 6GeNO, LLC
  Pipeline Products by Equipment Type 7GeNO, LLC
  Number of Pipeline Products by Development Stage
  8GeNO, LLC Pipeline Products by Development
  Stage 9GeNO, LLC Number of Pipeline Products by
  Therapy Area 10GeNO, LLC Pipeline Products by
  Therapy Area 11GeNO, LLC Number of Pipeline
  Products by Trial Phase 12GeNO, LLC Pipeline
  Products by Trial Phase 12GeNO, LLC Number of
  Pipeline Products By Milestone Summary 13GeNO,
  LLC Pipeline Products by Milestone Summary
  14GeNOSYL Nitrosyl Delivery Platform -
  Ambulatory System - Product Status 15GeNOSYL
  Nitrosyl Delivery Platform - Ambulatory System -
  Product Description 15NITROSYL System - Product
  Status 16NITROSYL System - Product Description
  16NITROSYL System - Product Milestone
  16NITROSYL System - An Open Label Pilot Study
  Evaluating Preliminary Safety and Performance of
  the GeNO Nitrosyl Delivery System 17NITROSYL
  System - Patent Details1 19NITROSYL System -
  Patent Details2 19NITROSYL System - Patent
  Details3 20NITROSYL System - Patent Details4
  20NITROSYL System - Patent Details5 21NITROSYL
  System - Patent Details6 21NITROSYL System -
  Patent Details7 22NITROSYL System - Patent
  Details8 22NITROSYL System - Patent Details9
  23Ventilator-Based Platform - Intensive Care
  Unit Use - Product Status 24Ventilator-Based
  Platform - Intensive Care Unit Use - Product
  Description 24GeNO, LLC, Key Employees 26GeNO,
  LLC, Other Locations 27
•  

6
List of Figures GeNO, LLC Pipeline
Products by Equipment Type 6GeNO, LLC Pipeline
Products by Development Stage 8GeNO, LLC
Pipeline Products by Therapy Area 10GeNO, LLC
Pipeline Products by Trial Phase 12GeNO, LLC
Pipeline Products by Milestone Summary 13 
7
Related Reports

• OptiMedica Corporation - Medical Equipment -
  Deals and Alliances Profile
• SuperSonic Imagine, SA - Medical Equipment -
  Deals and Alliances Profile
• MDwerks, Inc. (MDWK) - Medical Equipment - Deals
  and Alliances Profile
• Andover Medical, Inc. (ADOV) - Medical Equipment
  - Deals and Alliances Profile
• Certified Diabetic Services, Inc. - Medical
  Equipment - Deals and Alliances Profile
• Confirma Inc. - Medical Equipment - Deals and
  Alliances Profile
• SQI Diagnostics Inc. (SQD) - Medical Equipment -
  Deals and Alliances Profile
• Coapt Systems, Inc. - Medical Equipment - Deals
  and Alliances Profile
• VertiFlex Inc. - Medical Equipment - Deals and
  Alliances Profile
• Competitive Intelligence Leading Coagulation
  Market Players--Strategic Assessments of Major
  Suppliers and Emerging Market Entrants

8

• Contact Us
• Aarkstore Enterprise
• Tel [phone]
• Mobile No08149852585
• Email contact_at_aarkstore.com
• Website http//www.aarkstore.com
• Blog http//www.emarketreports.com
• http//teju-aarkstoreenterprise.blogspot.in
• Follow us on twitter http//twitter.com/aarkstore
  dotcom
• http//in.linkedin.com/in/aarkstore
• http//www.facebook.com/aarkstoreenterprise